Neuralstem’s treatment for amyotrophic lateral sclerosis (ALS), now into Phase 2 clinical trials, is getting more enthusiastic attention.

Ted Harada, diagnosed with the disease in 2010, has been a walking advertisement for their treatment after two surgeries that he underwent as part of the Phase 1 clinical trials at Emory University. The surgeries restored his balance and ability to walk.